# Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

> **NCT02801487** · PHASE1,PHASE2 · TERMINATED · sponsor: **Shanghai Proton and Heavy Ion Center** · enrollment: 6 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **RADIATION:** Carbon ion radiotherapy (CIRT)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02801487
- **Lead sponsor:** Shanghai Proton and Heavy Ion Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2017-01-01
- **Final completion:** 2017-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Slow accrual of patients.
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02801487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02801487, "Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02801487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*